Florbetaben

CHEMBL1908906 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

358.4 g/mol

LogP

4.2

Phase

4

This radioactive imaging agent is used in PET scans to help doctors detect amyloid plaques in the brain, which are associated with Alzheimer's disease.

Moleküler Ağırlık

358,4000 g/mol

LogP

4,20

TPSA

39,70 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Alzheimer's Disease Parkinson's Disease Multiple Sclerosis Stroke

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CNc1ccc(/C=C/c2ccc(OCCOCCOCCF)cc2)cc1

InChI

InChI=1S/C21H26FNO3/c1-23-20-8-4-18(5-9-20)2-3-19-6-10-21(11-7-19)26-17-16-25-15-14-24-13-12-22/h2-11,23H,12-17H2,1H3/b3-2+

Molecular Formula

C21H26FNO3

HBD / HBA

1 / 5

Döndürülebilir Bağlar

12

Ağır Atomlar

26

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

This radioactive imaging agent is used in PET scans to help doctors detect amyloid plaques in the brain, which are associated with Alzheimer's disease.

Yes, Florbetaben is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1908906. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 11501341. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Florbetaben PillFYI'da

Yapı

Hızlı Veriler

Formül: C21H26FNO3
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.